Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Novel Blood Multi-marker Test for the Detection of Colorectal Cancer Relapse

NCT04920955 is registered in ClinicalTrials.gov with Novigenix SA as lead sponsor.

NCT NCT04920955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04920955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Novel Blood Multi-marker Test for the Detection of Colorectal Cancer Relapse
Lead sponsor
Novigenix SA
Phase
Observational
Overall status
Completed
Start date
February 10, 2021
Completion date
January 31, 2024
Enrollment
264 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer